Do you want to improve your praxis in the handling of pathologies within the Genodermatoses with Oncogenic Potential? TECHhas prepared this complete program so that you can do it 100% online"

Genodermatosis is closely related to Cancer diagnosis.  Although not all patients who suffer from this skin disease end up developing cancerous pathologies, the truth is that, according to studies, they have a greater genetic predisposition that significantly increases the risk. For this reason, the identification of variants such as Neurofibromatosis or Tuberous Sclerosis should alert specialists. However, thanks to the advances that have been made and that continue to be made on an ongoing basis, it has been possible to establish increasingly effective preventive and therapeutic guidelines for the handling of these diseases.

It is precisely in this context that this Postgraduate certificate is focused, a complete and exhaustive qualification based on the latest developments associated with Genodermatoses with Oncogenic Potential. After arduous research and analysis, a group of experts and analysis, experts in Oncology, Dermatology and Radiotherapy have developed an innovative degree that includes 150 hours of theoretical, practical and additional content based on the analysis, advances in clinical handling, histopathology and treatment of the different variants of this pathology: Ehlers-Danlos Syndrome, Muir-Torre Syndrome, Nevoid Basal Cell Carcinoma, Pachyonychia Congenita, etc. 

All this compacted in a comfortable and accessible 100% online format. The specialist will be able to access the Virtual Campus from any device with internet connection, whether tablet, PC or cell phone. In addition, you can do it for 6 weeks, without limits and without timetables. This way, you will be able to work on improving your medical knowledge and your patient handling skills in a comfortable way, at your own pace and without pressure. All this will help you get up to date in diagnosis, prevention and therapy with the guarantee that TECH is the largest medical school in the world. 

A dynamic Postgraduate certificate that will allow you to approach your patients with an advanced and innovative vision"

This Postgraduate certificate in Genodermatoses with Oncogenic Potential contains the most complete and up-to-date scientific program on the market. The most important features include:  

• The development of case studies presented by experts in Oncology, Dermatology and Radiotherapy
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection 

You will work on improving your clinical skills for the analysis and treatment of multiple oncogenic pathologies through the best theoretical, practical and additional material"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this training program, as well as renowned specialists from leading societies and prestigious universities.  

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersion education programmed to learn in real situations.  

The design of this program focuses on Problem-Based Learning, by means of which the professional must try to solve the different professional practice situations that are presented throughout the academic course. This will be done with the help of an innovative system of interactive videos made by renowned experts.   

You will be able to access the Virtual Campus from any device with internet connection, whether it is a computer, tablet or cell phone"

You will delve into the new histopathological development techniques in Pseudoxanthoma Elasticum and the most innovative treatments that have been developed so far"

The teaching team has been working for weeks to develop the syllabus and resources that form part of this Postgraduate certificate. TECHrequires that all the material is based on the latest scientific developments, thus guaranteeing an exhaustive and intensive actualization. In addition, with the additional material, the graduates will be able to expand each section in a personalized way, allowing them to delve deeper into those aspects they consider most important for their clinical performance.  

Keep your Vademecum up to date with the latest oncogenic information and the invasive and non-invasive treatments for Genodermatoses that are currently showing the best results currently"

Module 1. Genodermatoses Predisposing to Skin Cancer 

1.1. Neurofibromatosis

1.1.1. Analysis of Neurofibromatosis  
1.1.2. Clinical features of neurofibromatosis  
1.1.3. Histopathology features of neurofibromatosis  
1.1.4. Treatment in neurofibromatosis  

1.2. Tuberous Sclerosis  

1.2.1. Tuberous Sclerosis Evaluation  
1.2.2. Clinical manifestations of Tuberous Sclerosis  
1.2.3. Histopathology manifestations of Tuberous Sclerosis  
1.2.4. Treatment in tuberous sclerosis  

1.3. Pseudoxanthoma elasticum  

1.3.1. Analysis of the elastic pseudoxanthoma  
1.3.2. Clinical features in Pseudoxanthoma elasticum  
1.3.3. Histopathology features in Pseudoxanthoma elasticum  
1.3.4. Treatment in pseudoxanthoma elasticum  

1.4. Ehlers-Danlos Syndrome  

1.4.1. Evaluation of Ehlers-Danols syndrome
1.4.2. Clinical features of Ehlers-Danols syndrome  
1.4.3. Histopathology in Ehlers-Danols syndrome  
1.4.4. Treatment in Ehlers-Danols syndrome  

1.5. Muir-Torre syndrome  

1.5.1. Analysis of the Muir-Torre Syndrome  
1.5.2. Muir-Torre Syndrome Clinic  
1.5.3. Histopathology in Muir-Torre Syndrome  
1.5.4. Treatment in Muir-Torre Syndrome  

1.6. Gorlin or nevoid basal cell carcinoma syndrome  

1.6.1. Evaluation of Gorlin's syndrome or nevoid basal cell carcinoma  
1.6.2. Clinical features of Gorlin's syndrome or nevoid basal cell carcinoma  
1.6.3. Histopathology features of Gorlin's syndrome or nevoid basal cell carcinoma  
1.6.4. Treatment in Gorlin's Syndrome or nevoid basal cell carcinoma

1.7. Cowden's syndrome (multiple hamartomas)  

1.7.1. Analysis of Cowden syndrome (multiple Hamartomas)
1.7.2. Clinic in Cowden syndrome (multiple Hamartomas)
1.7.3. Histopathology in Cowden's syndrome (multiple Hamartomas)  
1.7.4. Treatment in Cowden's syndrome (multiple Hamartomas)  

1.8. Gardner syndrome  

1.8.1. Evaluation of Gardner's Syndrome  
1.8.2. Clinical features of Gardner's syndrome  
1.8.3. Histopathology in Gardner's Syndrome  
1.8.4. Treatment in Gardner syndrome  

1.9. Pigmentovascular phakomatosis associated with hypochromic nevus   

1.9.1. Evaluation of pigmentovascular phakomatosis associated with hypochromic nevus
1.9.2. Clinical features of Pigmentovascular phakomatosis associated with hypochromic nevus  
1.9.3. Histopathology features of Pigmentovascular phakomatosis associated with hypochromic nevus  
1.9.4. Treatment features of Pigmentovascular phakomatosis associated with hypochromic nevus  

1.10. Congenital pachyonychia in multiple family members

1.10.1. Analysis of Pachyonychia congenita  
1.10.2. Clinical features of pachyonychia congenita  
1.10.3. Histopathology in Pachyonychia congenita  
1.10. 4 Treatment in Pachyonychia congenita  

A program that includes a guaranteed family congenital study, so that you can implement the latest strategies in preventive diagnosis in your practice"